Brolucizumab Monotherapy in Idiopathic Polypoidal Choroidal Vasculopathy:A Case Report
Brolucizumab a humanized single-chain antibody fragment targeting VEGF-A is approved for neovascular age-related macular degeneration nAMD and is being studied for other retinal conditions including polypoidal choroidal vasculopathy PCV. This case report presents a 79-year-old I...
Saved in:
| Main Authors: | Mohan S, Kalpana Badami, Shilpa Y D, Hemalata B C |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Rajiv Gandhi University of Health Sciences
2025-01-01
|
| Series: | RGUHS Journal of Medical Sciences |
| Online Access: | https://journalgrid.com/view/article/rjms/12434377 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Idiopathic polypoidal choroidal vasculopathy
by: Cekić Sonja, et al.
Published: (2012-01-01) -
Polypoidal Choroidal Vasculopathy in Congolese Patients
by: Nelly N. Kabedi, et al.
Published: (2020-01-01) -
Six Cases of Polypoidal Choroidal Vasculopathy in Eyes with Choroidal Nevi
by: Andrea Gaggino, et al.
Published: (2025-02-01) -
Polypoidal Choroidal Vasculopathy Treatment: Photodynamic Therapy, Anti-VEGF Monotherapy or Combination. Review of Clinical Studies
by: E. K. Pedanova, et al.
Published: (2019-06-01) -
Research status of clinicopathologic studies of polypoidal choroidal vasculopathy
by: LI Miaoling, et al.
Published: (2025-02-01)